Scale-up production and characterization of anti-human cardiac troponin I monoclonal antibody in ascitic fluid of balb/c mice

References

• (a) Pandey, S. Hybridoma Technology for Production of Monoclonal Antibodies. Hybridoma 2010, 1 (2), 017; (b) Zhang, C. Hybridoma Technology for the Generation of Monoclonal Antibodies. Antibody Meth. Protocols 2012, 117–135.
   Google Scholar
• Katrukha, I. Human Cardiac Troponin Complex. Structure and Functions. Biochemistry (Moscow) 2013, 78(13), 1447–1465.
   PubMed Web of Science ®Google Scholar
• (a) Babuin, L.; Jaffe, A.S. Troponin: The Biomarker of Choice for the Detection of Cardiac Injury. Can. Med. Assoc. J. 2005, 173(10), 1191–1202; (b) Reichlin, T.; Hochholzer, W.; Bassetti, S.; Steuer, S.; Stelzig, C.; Hartwiger, S.; Biedert, S.; Schaub, N.; Buerge, C.; Potocki, M. Early Diagnosis of Myocardial Infarction with Sensitive Cardiac Troponin Assays. New Engl. J. Med. 2009, 361(9), 858–867.
   Google Scholar
• O’Gara, P.T.; Kushner, F.G.; Ascheim, D.D.; Casey, D.E.; Chung, M.K.; De Lemos, J.A.; Ettinger, S.M.; Fang, J.C.; Fesmire, F.M.; Franklin, B.A. 2013 ACCF/AHA Guideline for the Management of ST-elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J. Am. College Cardiol. 2013, 61(4), e78–e140.
   PubMed Web of Science ®Google Scholar
• Tiwari, R.P.; Jain, A.; Khan, Z.; Kohli, V.; Bharmal, R.; Kartikeyan, S.; Bisen, P.S. Cardiac Troponins I and T: Molecular Markers for Early Diagnosis, Prognosis, and Accurate Triaging of Patients with Acute Myocardial Infarction. Molec. Diagn. Therapy 2012, 16(6), 371–381.
   Google Scholar
• Lee, G.; Liu, S. Monoclonal Antibodies Against Human Cardiac Troponin I for Immunoassays II. Monoclonal Antibod. Immunodiagn. Immunother. 2015, 34(3), 169–173.
   PubMedGoogle Scholar
• Brodeur, B.R.; Tsang, P.S. High Yield Monoclonal Antibody Production in Ascites. J. Immunolog. Meth. 1986, 86(2), 239–241.
   PubMed Web of Science ®Google Scholar
• (a) McArdle, J. Alternatives to Ascites Production of Monoclonal Antibodies. Animal Welfare Inform. Center Newslett. (USA) 1997; (b) Falkenberg, F.; Weichert, H.; Krane, M.; Bartels, I.; Palme, M.; Nagels, H.-O.; Fiebig, H. In vitro Production of Monoclonal Antibodies in High Concentration in a New and Easy to Handle Modular Minifermenter. J. Immunolog. Meth. 1995, 179(1), 13–29; (c) Antibodies, N.R.C.C.o.M.o.P.M. In Vitro Production of Monoclonal Antibody, 1999.
   Google Scholar
• Baradaran, B.; Majidi, J.; Hassan, Z.; Abdolalizadeh, J. Large Scale Production and Characterization of Anti-human IgG Monoclonal Antibody in Peritoneum of Balb/c Mice. Am. J. Biochem. Biotechnol. 2006, 1(4), 190–193.
   Google Scholar
• Hadavi, R.; Zarnani, A.H.; Ahmadvand, N.; Mahmoudi, A.R.; Bayat, A.A.; Mahmoudian, J.; Sadeghi, M.-R.; Soltanghoraee, H.; Akhondi, M.M.; Tarahomi, M. Production of Monoclonal Antibody against Human Nestin. Avicenna J. Med. Biotechnol. 2010, 2(2), 69–77.
   PubMedGoogle Scholar
• Costagliola, S.; Franssen, J.; Bonomi, M.; Urizar, E.; Willnich, M.; Bergmann, A.; Vassart, G. Generation of a Mouse Monoclonal TSH Receptor Antibody with Stimulating Activity. Biochem. Biophys. Res. Commun. 2002, 299(5), 891–896.
   Google Scholar
• Grodzki, A.C.; Berenstein, E. Antibody Purification: Affinity Chromatography–Protein A and Protein G Sepharose. Immunocytochem. Meth. Protocols 2010, 33–41.
   Google Scholar
• Craig, T.A.; Sommer, S.L.; Beito, T.G.; Kumar, R. Production and Characterization of Monoclonal Antibodies to Human Sclerostin. Hybridoma 2009, 28(5), 377–381.
   PubMedGoogle Scholar
• Nejad-Moghaddam, A.; Abolhassani, M. Production and Characterization of Monoclonal Antibodies Recognizing a Common 57-kDa Antigen of Leishmania Species. Iran. Biomed. J. 2009, 13(4), 245.
   PubMedGoogle Scholar
• Tabll, A.; Abbas, A.T.; El-Kafrawy, S.; Wahid, A. Monoclonal Antibodies: Principles and Applications of Immmunodiagnosis and Immunotherapy for Hepatitis C virus. World J. Hepatol. 2015, 7(22), 2369.
   PubMedGoogle Scholar
• Ecker, D.M.; Jones, S.D.; Levine, H.L. In The Therapeutic Monoclonal Antibody Market, MAbs. Taylor & Francis, 2015; pp. 9–14.
   Google Scholar
• Ezzatifar, F.; Majidi, J.; Baradaran, B.; Maleki, L.A.; Abdolalizadeh, J.; Yousefi, M. Large Scale Generation and Characterization of Anti-Human IgA Monoclonal Antibody in Ascitic Fluid of Balb/c Mice. Adv. Pharmaceut. Bull. 2015, 5(1), 97.
   PubMed Web of Science ®Google Scholar
• Peterson, N.C.; Peavey, J.E. Comparison of in vitro Monoclonal Antibody Production Methods with an in vivo Ascites Production Technique. J. Am. Assoc. Lab. Animal Sci., 1998, 37(5), 61–66.
   Google Scholar
• Kozlowski, S.; Swann, P. Current and Future Issues in the Manufacturing and Development of Monoclonal Antibodies. Adv. Drug Deliv. Rev. 2006, 58(5), 707–722.
   PubMed Web of Science ®Google Scholar
• Peterson, N.C. Behavioral, Clinical, and Physiologic Analysis of Mice used for Ascites Monoclonal Antibody Production. Compar. Med. 2000, 50(5), 516–526.
   PubMed Web of Science ®Google Scholar
• Darcy, E.; Leonard, P.; Fitzgerald, J.; Danaher, M.; O’Kennedy, R. Purification of Antibodies using Affinity Chromatography. Protein Chromatogr. Meth. Protocols 2011, 369–382.
   Google Scholar
• National Research Council Committee on Methods of Producing Monoclonal, A. The National Academies Collection: Reports funded by National Institutes of Health. In Monoclonal Antibody Production, National Academies Press (US), National Academy of Sciences.: Washington (DC), 1999.
   Google Scholar
• Etheridge, M.E. Alternatives to Monoclonal Antibody Production (Proceedings). Avialable at http://altweb.jhsph.edu/pubs/proceedings/mab/etheridge.html.
   Google Scholar